Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-14

Clinical Trial Results: Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing self-directed titrated transdermal nicotine patch to standard treatment for smoking cessation; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • transdermal nicotine patch (self-directed titrated)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED | Results posted: 2026-08-14